Trima

What Trima does

Trima is an Israeli pharmaceutical company specializing in the development, manufacturing, and marketing of generic drugs, founded in 1935 and wholly owned by Kibbutz Ma'abarot since 2018. The company operates an EU-GMP certified production facility in Ma'abarot, Israel, manufacturing Rx and OTC pharmaceuticals in tablets, capsules, gels, creams, powders, syrups, and sprays across therapeutic areas including dermatology, respiratory, CNS, muscular-skeletal pain, allergy, and cough/cold. Its portfolio comprises over 60 internally developed generic products plus approximately 10 licensed/imported products distributed in the Israeli market.

Trima runs a vertically integrated value chain covering R&D, regulatory affairs, manufacturing, logistics, and sales and marketing. The company pursues a dual business model: (1) proprietary generic drug development and direct sales to Israeli institutional buyers and the private market, and (2) partnership-driven distribution — in-licensing international Rx, OTC, and medical device products for the Israeli market, and out-licensing its in-house developed products to international partners for private label and distribution arrangements.

Leadership is drawn from major pharmaceutical companies including Teva, Taro Pharmaceuticals, and Johnson & Johnson. Trima maintains a global partner network including Dr Fisher, Cooper, Grimberg, BMG Pharma, HARRAS, Megapharm, Trenker, Gedeon Richter, Kern, Velit, Aldo Union, and Pramit. The company is currently expanding capacity through construction of a new manufacturing campus at its Kibbutz Ma'abarot site.

Name

Trima

Legal name

Trima Israel Pharmaceutical Products Maabrot Ltd.

Website

https://trima.co.il

Company type

Private

Founded year

1935

Operating status

Operating

Headcount range

11–50 employees

Short description

Trima is an Israeli pharmaceutical company that develops, manufactures, and markets generic Rx and OTC drugs across multiple therapeutic areas, operating an EU-GMP facility and serving both the Israeli market and international licensing partners.

Ownership category

akta.pro rank

Product category

Generic Pharmaceuticals

NAICS

Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Small-Molecule Generics (Branded/Unbranded) (HLAIABAA)

akta.pro secondary industry

Generic Hospital & Institutional Products (HLAIABAL)

Keywords

• Generic pharmaceuticals
• Drug manufacturing
• In-licensing services
• Out-licensing services
• Pharmaceutical distribution

Headquarters

HQ city

Agudat Israel

HQ country

Israel

HQ region

Middle East

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Generic Drug Manufacturing and Sales: Development, manufacturing and marketing of internally developed generic pharmaceutical products including Rx and OTC drugs across multiple therapeutic areas
2. In-Licensing and Distribution: Partnering with international companies to license, register, and distribute their products (Rx, OTC, Medical Devices) in the Israeli market, handling regulatory support, logistics, and sales and marketing
3. Out-Licensing and Private Label: Expanding marketing partnerships for products developed in-house, providing regulatory support, flexible manufacturing capabilities and logistics to partners

Go-to-market motion2 records

Distribution channels2 records

Marketing channels2 records

Core offering

Trima develops, manufactures, and markets a portfolio of generic pharmaceutical products (Rx and OTC) in multiple dosage forms including tablets, capsules, creams, gels, ointments, powders, syrups, and sprays. Its offering includes over 60 internally developed generic products plus approximately 10 licensed/imported products distributed in Israel. The company also provides in-licensing and distribution services for international pharma companies entering the Israeli market, and out-licensing/private label services for its own in-house developed products.

Product overview

Trima is a pharmaceutical company offering a unified portfolio centered on generic drug development, manufacturing, and marketing. The portfolio consists of over 60 internally developed generic pharmaceutical products (Rx and OTC) plus approximately 10 licensed/imported products, spanning therapeutic areas including dermatology, respiratory, CNS, muscular-skeletal pains, allergy, and cough and cold. Products are manufactured in various forms including tablets, capsules, creams, gels, ointments, powders, syrups, and sprays. Complementing the product portfolio, Trima provides in-licensing and distribution services for international partners seeking market entry, as well as out-licensing and private label services enabling partners to market Trima's in-house developed products.

Differentiator

Problem solved

Functional benefit

Products and services

• Generic Pharmaceuticals (Internal Development) Over 60 generic pharmaceutical products developed internally at Trima, including Rx (prescription) and OTC (over-the-counter) drugs across therapeutic areas including dermatology, respiratory, CNS, muscular-skeletal pains, allergy, and cough and cold. Manufactured at the EU-GMP certified facility in Israel in forms such as tablets, capsules, creams, gels, ointments, powders, syrups, and sprays.
• Licensed / Imported Pharmaceutical Products

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

Twelve partnerships are on record, tiered core.

• Dr FishercoreGTM or Marketing PartnerLogo partner displayed on Trima website as part of global partners section, indicating collaborative relationship for product distribution or marketing.
• CoopercoreGTM or Marketing PartnerLogo partner displayed on Trima website as part of global partners section, indicating collaborative relationship for product distribution or marketing.
• GrimbergcoreGTM or Marketing PartnerLogo partner displayed on Trima website as part of global partners section, indicating collaborative relationship for product distribution or marketing.
• BMG PharmacoreGTM or Marketing PartnerLogo partner displayed on Trima website as part of global partners section, indicating collaborative relationship for product distribution or marketing.
• HARRAScoreGTM or Marketing PartnerLogo partner displayed on Trima website as part of global partners section, indicating collaborative relationship for product distribution or marketing.
• MegapharmcoreGTM or Marketing PartnerLogo partner displayed on Trima website as part of global partners section, indicating collaborative relationship for product distribution or marketing.
• TrenkercoreGTM or Marketing PartnerLogo partner displayed on Trima website as part of global partners section, indicating collaborative relationship for product distribution or marketing.
• Gedeon RichtercoreGTM or Marketing PartnerLogo partner displayed on Trima website as part of global partners section, indicating collaborative relationship for product distribution or marketing.
• KerncoreGTM or Marketing PartnerLogo partner displayed on Trima website as part of global partners section, indicating collaborative relationship for product distribution or marketing.
• VelitcoreGTM or Marketing PartnerLogo partner displayed on Trima website as part of global partners section, indicating collaborative relationship for product distribution or marketing.
• Aldo UnioncoreGTM or Marketing PartnerLogo partner displayed on collaborations page, indicating partnership for in-licensing, distribution or collaborative product efforts.
• PramitcoreGTM or Marketing PartnerLogo partner displayed on collaborations page, indicating partnership for in-licensing, distribution or collaborative product efforts.

Scale indicators5 records

Recent moves10 records

Expansion highlights4 records

Broad incumbents

• Teva Pharmaceutical Industries: Israel's largest generic drug manufacturer and a global broad incumbent in pharmaceuticals. Comparably positioned as an Israeli generic pharma with R&D, manufacturing, and commercial operations, though at vastly larger scale and global reach than Trima.
• Taro Pharmaceutical Industries: Israeli generic and specialty pharmaceutical company, formerly led by Trima's current Chairman Shmuel Rubinstein. Comparable as an Israel-headquartered generic drug manufacturer with multi-form capabilities serving both U.S. and international markets.
• Perrigo Company: Global leader in consumer self-care and generic pharmaceuticals with strong OTC/Rx portfolio. Comparable as a broad incumbent in branded generics and OTC manufacturing, though operating at significantly larger scale across multiple geographies.
• Viatris: Global healthcare company formed from Mylan and Upjohn with extensive generic and branded pharmaceutical portfolio. Comparable as a broad incumbent in multi-form generic manufacturing across multiple therapeutic areas.
• Sandoz (Novartis): Global leader in generic pharmaceuticals and biosimilars, spun off from Novartis. Comparable as a broad incumbent in generic drug development and manufacturing across diverse dosage forms and therapeutic categories.
• Dr. Reddy's Laboratories: Indian-headquartered global pharmaceutical company with strong generics portfolio across multiple dosage forms. Comparable as a broad incumbent offering branded generics and active pharmaceutical ingredients internationally.
• Gedeon Richter: Hungarian-headquartered multinational pharmaceutical company with generics and specialty pharma operations. Comparable as a European-headquartered broad incumbent in generic drug manufacturing with whom Trima has a listed partnership relationship.

Direct peers

• Dexcel Pharma Israel: Israel-based specialty and generic pharmaceutical company with development, manufacturing, and marketing operations. Directly comparable in size, Israeli market focus, generic drug portfolio, and multi-form manufacturing capabilities.
• Unipharm Israel: Israeli pharmaceutical manufacturer that was historically Trima's partner through Motivan. Directly comparable as an Israel-based generic pharma with overlapping therapeutic categories and private-label/in-licensing business model.
• Megapharm: Israeli pharmaceutical company focused on marketing and distribution of pharmaceutical products. Directly comparable as an Israel-based pharma partner in Trima's in-licensing network, operating with similar Israeli-market focus.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/trima-pharmaceutical-products

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles9 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Trima